Lysophospholipids increase interleukin-8 expression in ovarian cancer cells

Gynecologic Oncology

Volumn 81, Issue 2, 2001, Pages 291-300

  Schwartz, Benjamin M ^a   Hong, Guiying ^a   Morrison, Bei H ^a   Wu, Weihua ^a   Baudhuin, Linnea M ^a,b   Xiao, Yi Jin ^a   Mok, Samuel C ^c   Xu, Yan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Interleukin 8; Lysophosphatidic acid; Ovarian cancer; Sphingosine 1 phosphate; Sphingosylphosphorylcholine (SPC)

Indexed keywords

INTERLEUKIN 8; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE;

ARTICLE; ASCITES FLUID; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NORTHERN BLOTTING; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0035025317     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6124     Document Type: Article

References (28)

1. A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization, and mechanism of action
2. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells
3. Growth factors in human ovarian cancer
4. Human ovarian cancer of the surface epithelium
5. Biological therapy of ovarian cancer: Current directions
6. Lysophospholipids activate ovarian and breast cancer cells
7. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
8. Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells
9. Ascitic fluids from ovarian cancer patients contain significantly higher levels of lysophospholipids, compared with ascites from patient with non-malignant diseases
10. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
11. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells
12. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2
13. Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases
14. Interleukin-8 as a macrophage-derived mediator of angiogenesis
15. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
16. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
17. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma
18. Tumor-host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
19. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice
20. Zytokinspiegel im malignen aszites und peripheren blut von patientinnen mit fortgeschrittenem ovarialkarzinom
21. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
22. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
23. The chemotactic cytokine interleukin-8: A cyst fluid marker for malignant epithelial ovarian cancer?
24. Comparative properties of five human ovarian adenocarcinoma cell lines
25. Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma
26. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs)
27. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs. non-malignant ascitic fluids